LIQUID E-Z-PAQUE Drug Patent Profile
✉ Email this page to a colleague
When do Liquid E-z-paque patents expire, and when can generic versions of Liquid E-z-paque launch?
Liquid E-z-paque is a drug marketed by Bracco and is included in one NDA.
The generic ingredient in LIQUID E-Z-PAQUE is barium sulfate. One supplier is listed for this compound. Additional details are available on the barium sulfate profile page.
Summary for LIQUID E-Z-PAQUE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 104 |
Clinical Trials: | 1,492 |
Patent Applications: | 9 |
Formulation / Manufacturing: | see details |
DailyMed Link: | LIQUID E-Z-PAQUE at DailyMed |
Recent Clinical Trials for LIQUID E-Z-PAQUE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Advanced Integrative Medical Science Institute | Phase 1 |
Rgene Corporation | Phase 1/Phase 2 |
American BriVision Corporation | Phase 1/Phase 2 |
Pharmacology for LIQUID E-Z-PAQUE
Drug Class | Radiographic Contrast Agent |
Mechanism of Action | X-Ray Contrast Activity |
US Patents and Regulatory Information for LIQUID E-Z-PAQUE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bracco | LIQUID E-Z-PAQUE | barium sulfate | SUSPENSION;ORAL | 208143-003 | Mar 1, 2017 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |